Development of a Selective, Theranostic Nanoplatform to Inhibit Human Monoacylglycerol Lipase

Development of a Selective, Theranostic Nanoplatform to Inhibit Human Monoacylglycerol Lipase

Student: Michael Johnson
Department: Pharmaceutical Sciences
Advisor: Alex Makriyannis

Abstract: see biography.